## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi
✦ LIBER ✦
Interferon α increases toxicity of cisplatin + 5-fluorouracil in patients with relapsed squamous cell carcinoma of the head and neck
✍ Scribed by Nicolson, MC; Lorentzos, A; A'Hern, RP; Atkinson, HA; Gore, ME
- Book ID
- 122484553
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 170 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Paclitaxel, cisplatin, and 5-fluorouraci
✍
Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 73 KB
👁 3 views
Carboplatin and 5-Fluorouracil in squamo
✍
M. Benasso; G. Numico; M. Merlano
📂
Article
📅
1997
🏛
Elsevier Science
🌐
English
⚖ 265 KB
Cisplatin and 5-fluorouracil chemotherap
✍
Sacks, H.G.
📂
Article
📅
1988
🏛
Elsevier Science
🌐
English
⚖ 155 KB
Modified Combination Chemotherapy of Cis
✍
Furukawa, Shigeru; Tsukuda, Mamoru; Mochimatsu, Izumi; Kokatsu, Toshiyuki; Satoh
📂
Article
📅
1994
🏛
Elsevier Science
🌐
English
⚖ 321 KB
Pilot study of intraoperative chemothera
✍
Ozlem E. Tulunay; Ileana I. Enamorado; Omer Kucuk; Lance K. Heilbrun; Jose E. Ot
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 95 KB
👁 3 views
## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat
Cisplatin and 5-fluorouracil chemotherap
✍
Richard J. Mercier; G. David Neal; Douglas E. Mattox; George A. Gates; Thomas C.
📂
Article
📅
1987
🏛
John Wiley and Sons
🌐
English
⚖ 404 KB
👁 3 views